Semler Scientific, Inc. - Common Stock (SMLR)
38.79
-2.25 (-5.48%)
NASDAQ · Last Trade: Jun 26th, 7:01 PM EDT
Detailed Quote
Previous Close | 41.04 |
---|---|
Open | 40.66 |
Bid | 38.50 |
Ask | 39.30 |
Day's Range | 36.56 - 41.00 |
52 Week Range | 21.77 - 81.56 |
Volume | 1,859,641 |
Market Cap | 281.86M |
PE Ratio (TTM) | -16.23 |
EPS (TTM) | -2.4 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 1,290,973 |
Chart
About Semler Scientific, Inc. - Common Stock (SMLR)
Semler Scientific is a healthcare technology company that specializes in developing innovative solutions to enhance the efficiency and accuracy of diagnostic and measurement processes in medical settings. The company focuses on creating proprietary products that allow healthcare providers to assess patients more effectively, particularly in relation to cardiovascular and respiratory health. By leveraging advanced technology and data analytics, Semler aims to improve patient outcomes and streamline interactions between healthcare professionals and patients, ultimately contributing to better overall healthcare delivery. Read More
News & Press Releases
NEW YORK, NY / ACCESS Newswire / June 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Semler Scientific Inc. ("Semler" or the "Company") (NASDAQ:SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Via ACCESS Newswire · June 26, 2025
NEW YORK CITY, NY / ACCESS Newswire / June 25, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Semler Scientific Inc. ("Semler" or the "Company") (NASDAQ:SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Via ACCESS Newswire · June 25, 2025
NEW YORK CITY, NY / ACCESS Newswire / June 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Semler Scientific Inc. ("Semler" or the "Company") (NASDAQ:SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Via ACCESS Newswire · June 24, 2025
NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Arvinas, Inc. (NASDAQ:ARVN), Semler Scientific Inc. (NASDAQ:SMLR), and Abacus Global Management, Inc. (NASDAQ:ABL). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · June 23, 2025
NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · June 23, 2025
Via The Motley Fool · June 21, 2025
NEW YORK CITY, NY / ACCESS Newswire / June 20, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Semler Scientific Inc. ("Semler" or the "Company") (NASDAQ:SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Via ACCESS Newswire · June 20, 2025
Semler Scientific (NASDAQ:SMLR), one of the earliest publicly traded U.S.
Via Benzinga · June 20, 2025
Via Benzinga · June 20, 2025
NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · June 18, 2025
NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Landstar System, Inc. (NASDAQ:LSTR), EchoStar Corporation (NASDAQ:SATS), Semler Scientific Inc. (NASDAQ:SMLR), and ADTRAN Holdings, Inc. (NASDAQ:ADTN). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · June 16, 2025
NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · June 16, 2025
NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · June 15, 2025
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · June 13, 2025
Via Benzinga · June 12, 2025
Via The Motley Fool · June 11, 2025
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · June 10, 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Semler Scientific Inc. (NASDAQ:SMLR), ADTRAN Holdings, Inc. (NASDAQ:ADTN), and Fulgent Genetics, Inc. (NASDAQ: FLGT). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · June 9, 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · June 9, 2025
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · June 6, 2025

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against EchoStar Corporation (NASDAQ:SATS), Semler Scientific Inc. (NASDAQ:SMLR), ADTRAN Holdings, Inc. (NASDAQ:ADTN), and Fulgent Genetics, Inc. (NASDAQ: FLGT). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · June 2, 2025

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · June 2, 2025

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · June 2, 2025

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from allegations that Semler Scientific may have issued materially misleading business information to the investing public.
By The Rosen Law Firm, P.A. · Via Business Wire · May 29, 2025